Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody – ab313646

This content is brought to you by Abcam, a Danaher Operating Company.

We recognize the complexity and importance of selecting the right antibody clone during the early stages of your development program. Finding a clone that is both highly specific and sensitive to your intended target can be a daunting task. To mitigate the risks associated with this critical selection process, we have generated enhanced validation data for our top recombinant antibody clones targeting some of the most promising molecules. This enhanced validation provides you with an additional layer of confidence in your chosen antibody clone and offers comprehensive data on the specificity and sensitivity of our recombinant antibodies in immunohistochemistry (IHC).

Tailored specifically to the target and the pertinent research in clinical settings, we ensure that it meets the unique requirements of your project. Access the full application note to learn more.